Baricitinib for Cutaneous Dermatomyositis

Condition:   Dermatomyositis Intervention:   Drug: Baricitinib Sponsor:   University of Washington Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials